OAKBROOK TERRACE, Ill., April 11 /PRNewswire-USNewswire/ -- Medications specifically made for adults and administered to children in health care facilities are putting young patients at greater risk ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

The pediatric population is an extremely diverse group of patients, varying in size from less than 500 grams to greater than 100 kg and in age from minutes old to 18 years of age. Often, it is ...

Prescribing medications for kids requires unique considerations such as lower body weight, which could lead even small errors to cause patient harm. Yet little is known about how EHR usability issues ...

On Aug. 29, the FDA approved Afinitor Disperz (everolimus tablets for oral suspension), making it the first pediatric dosage approved for a pediatric tumor. While Afinitor has previously been ...

Recommendations to prevent MEs in the pediatric inpatient setting have been provided by the American Academy of Pediatrics Committee on Drugs and the Committee on Hospital Care, [52] the Institute for ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of all teens with a history of cardiac surgery still used more than one medication. Clinicians must ...

Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...

Children younger than 5 who live in economically disadvantaged areas had a greater risk of medication poisoning that resulted in referral to a health care facility, according to scientists. These ...

Cost-Effectiveness of Oral Levofloxacin Versus Amoxicillin-Clavulanate/Ciprofloxacin for Outpatient Management of Low-Risk Febrile Neutropenia in Children With Cancer ...